Exagen Inc.XGNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P50
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-2.61%
20248.18%
202355.01%
2022-58.59%
2021-43.92%
2020-45.03%
2019-4.41%
201815.20%
20170.00%
2015-10.48%